Oscar Health, Inc. (OSCR) Surpasses Market Returns: Some Facts Worth Knowing

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $15.35, marking a +2.88% move from the previous day. This change outpaced the S&P 500's 0.32% gain on the day. Elsewhere, the Dow gained 0.53%, while the tech-heavy Nasdaq added 0.26%. Prior to today's trading, shares of the company had lost 7.39% lagged the Finance sector's gain of 3.04% and the S&P 500's gain of 4.51%.The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company is forecasted to report an EPS of $0.11, showcasing a 45% downward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $2.8 billion, up 25.98% from the year-ago period. For the annual period, the Zacks Consensus Estimates anticipate earnings of $0.58 per share and a revenue of $11.14 billion, signifying shifts of +480% and +21.39%, respectively, from the last year. Investors should also pay attention to any latest changes in analyst estimates for Oscar Health, Inc. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook. Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the last 30 days, the Zacks Consensus EPS estimate has moved 5.98% lower. Right now, Oscar Health, Inc. possesses a Zacks Rank of #4 (Sell). From a valuation perspective, Oscar Health, Inc. is currently exchanging hands at a Forward P/E ratio of 25.87. This valuation marks a premium compared to its industry average Forward P/E of 9.86. The Insurance - Multi line industry is part of the Finance sector. At present, this industry carries a Zacks Industry Rank of 92, placing it within the top 38% of over 250 industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Ensure to harness Zacks.com to stay updated with all these stock-shifting metrics, among others, in the next trading sessions. Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks